Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mind Media is a neurotechnology and health diagnostics company that develops commercial biofeedback, neurofeedback, and quantitative electroencephalography (qEEG) systems for clinical, research, and educational use. Its core product family includes the NeXus hardware line and BioTrace+ software, which together support multimodal physiological measurement, nervous system training, and brain-function assessment. The company serves clinicians, researchers, hospitals, and neurotherapy practices rather than operating as a therapeutics developer. Mind Media positions itself at the intersection of psychophysiology, neuroscience, and applied neurotechnology, with products used across neurohealth, mental health, and human performance settings. Its business model appears centered on device sales, software, training, and support for a global installed base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mind Media.